Robeco Institutional Asset Management B.V. Has $54.99 Million Position in Centene Co. (NYSE:CNC)

Robeco Institutional Asset Management B.V. trimmed its position in Centene Co. (NYSE:CNC) by 7.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 907,692 shares of the company’s stock after selling 72,302 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Centene were worth $54,988,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Park Place Capital Corp increased its position in Centene by 1,190.0% in the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after purchasing an additional 357 shares during the period. Private Trust Co. NA boosted its stake in shares of Centene by 75.3% in the 3rd quarter. Private Trust Co. NA now owns 773 shares of the company’s stock valued at $58,000 after purchasing an additional 332 shares during the last quarter. True Wealth Design LLC acquired a new stake in shares of Centene during the 3rd quarter worth approximately $66,000. R Squared Ltd acquired a new position in Centene in the fourth quarter valued at approximately $82,000. Finally, Venturi Wealth Management LLC boosted its stake in Centene by 77.3% in the third quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company’s stock valued at $88,000 after acquiring an additional 507 shares during the last quarter. Institutional investors own 93.63% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on CNC. StockNews.com raised Centene from a “buy” rating to a “strong-buy” rating in a research note on Monday. Sanford C. Bernstein cut their target price on Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 30th. Cantor Fitzgerald restated an “overweight” rating and set a $90.00 target price on shares of Centene in a research report on Wednesday, December 11th. UBS Group upgraded shares of Centene from a “neutral” rating to a “buy” rating and increased their price target for the company from $79.00 to $80.00 in a research report on Friday, December 13th. Finally, Truist Financial lowered their target price on shares of Centene from $89.00 to $84.00 and set a “buy” rating for the company in a research note on Friday, December 13th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $80.92.

Insider Transactions at Centene

In other Centene news, Director H James Dallas purchased 1,693 shares of the business’s stock in a transaction on Monday, December 16th. The shares were purchased at an average cost of $59.01 per share, with a total value of $99,903.93. Following the transaction, the director now directly owns 1,693 shares of the company’s stock, valued at $99,903.93. This represents a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Thomas Greco acquired 17,000 shares of the firm’s stock in a transaction dated Wednesday, December 18th. The stock was bought at an average price of $59.75 per share, with a total value of $1,015,750.00. Following the acquisition, the director now directly owns 19,309 shares in the company, valued at $1,153,712.75. This represents a 736.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 45,010 shares of company stock valued at $2,660,276 over the last 90 days. 0.33% of the stock is owned by corporate insiders.

Centene Stock Down 1.3 %

NYSE:CNC opened at $63.89 on Thursday. Centene Co. has a 52-week low of $55.03 and a 52-week high of $81.42. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. The stock has a 50-day simple moving average of $60.91 and a 200 day simple moving average of $67.21. The company has a market cap of $32.26 billion, a PE ratio of 11.09, a PEG ratio of 0.85 and a beta of 0.45.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.